The use of low-dose carvedilol did not significantly improve certain cardiac measures of heart failure risk in long-term survivors of childhood cancer exposed to anthracycline compared with placebo, ...

March 17, 2006 (Atlanta) — Tens of thousands of lives could be saved if all eligible patients hospitalized with heart failure were discharged on beta-blockers, according to researchers who found that ...

Please provide your email address to receive an email when new articles are posted on . A low-dose regimen of the blood pressure medication carvedilol demonstrated safety and efficacy in improving ...

Carvedilol, the nonselective beta 1,2 - and alpha 1-adrenergic receptor blocker, is approved in the United States, Europe, and other parts of the world for treatment of chronic heart failure (HF) in ...